• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Erratum to: Frequency of germline DNA genetic findings in an unselected prospective cohort of triple-negative breast cancer patients participating in a platinum-based neoadjuvant chemotherapy trial.

作者信息

González-Rivera Milagros, Lobo Miriam, López-Tarruella Sara, Jerez Yolanda, Del Monte-Millán María, Massarrah Tatiana, Ramos-Medina Rocío, Ocaña Inmaculada, Picornell Antoni, Santillán Garzón Sonia, Pérez-Carbornero Lucía, García-Saenz José A, Gómez Henry, Moreno Fernando, Márquez-Rodas Iván, Fuentes Hugo, Martin Miguel

机构信息

Medical Oncology Service, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Hospital General Universitario Gregorio Marañón, Madrid, Spain.

Medical Genetics Unit, Sistemas Genómicos SA, Valencia, Spain.

出版信息

Breast Cancer Res Treat. 2017 Sep;165(2):471. doi: 10.1007/s10549-017-4396-0.

DOI:10.1007/s10549-017-4396-0
PMID:28721639
Abstract
摘要

相似文献

1
Erratum to: Frequency of germline DNA genetic findings in an unselected prospective cohort of triple-negative breast cancer patients participating in a platinum-based neoadjuvant chemotherapy trial.对以下文章的勘误：参与铂类新辅助化疗试验的未选择的三阴性乳腺癌患者前瞻性队列中种系DNA遗传发现的频率。
Breast Cancer Res Treat. 2017 Sep;165(2):471. doi: 10.1007/s10549-017-4396-0.
2
Frequency of germline DNA genetic findings in an unselected prospective cohort of triple-negative breast cancer patients participating in a platinum-based neoadjuvant chemotherapy trial.参与铂类新辅助化疗试验的未选择的三阴性乳腺癌患者前瞻性队列中种系DNA遗传发现的频率。
Breast Cancer Res Treat. 2016 Apr;156(3):507-515. doi: 10.1007/s10549-016-3792-1. Epub 2016 Apr 15.
3
Clinical Implications of iNOS Levels in Triple-Negative Breast Cancer Responding to Neoadjuvant Chemotherapy.诱导型一氧化氮合酶水平在新辅助化疗反应性三阴性乳腺癌中的临床意义
PLoS One. 2015 Jul 21;10(7):e0130286. doi: 10.1371/journal.pone.0130286. eCollection 2015.
4
Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial.新辅助卡铂治疗三阴性和 HER2 阳性早期乳腺癌患者（GeparSixto；GBG 66）：一项随机 2 期试验。
Lancet Oncol. 2014 Jun;15(7):747-56. doi: 10.1016/S1470-2045(14)70160-3. Epub 2014 Apr 30.
5
ERCC1 Expression in Metastatic Triple Negative Breast Cancer Patients Treated with Platinum-Based Chemotherapy.接受铂类化疗的转移性三阴性乳腺癌患者的ERCC1表达情况
Asian Pac J Cancer Prev. 2017 Feb 1;18(2):507-513. doi: 10.22034/APJCP.2017.18.2.507.
6
[Not Available].[无可用内容]
Bull Cancer. 2016 Jun;103(6 Suppl 1):S76-89. doi: 10.1016/S0007-4551(16)30149-7.
7
Strong cytoplasmic expression of NF-κB/p65 correlates with a good prognosis in patients with triple-negative breast cancer.NF-κB/p65的强细胞质表达与三阴性乳腺癌患者的良好预后相关。
Surg Today. 2016 Jul;46(7):843-51. doi: 10.1007/s00595-015-1265-5. Epub 2015 Oct 22.
8
Platinum agents in the treatment of early-stage triple-negative breast cancer: is it time to change practice?铂类药物在早期三阴性乳腺癌治疗中的应用：是时候改变治疗方案了吗？
Clin Adv Hematol Oncol. 2014 Oct;12(10):654-8.
9
Chemotherapy of metastatic triple negative breast cancer: Experience of using platinum-based chemotherapy.转移性三阴性乳腺癌的化疗：铂类化疗的应用经验
Oncotarget. 2015 Dec 15;6(40):43135-43. doi: 10.18632/oncotarget.5654.
10
Exome sequencing reveals frequent deleterious germline variants in cancer susceptibility genes in women with invasive breast cancer undergoing neoadjuvant chemotherapy.外显子组测序揭示了接受新辅助化疗的浸润性乳腺癌女性患者癌症易感基因中频繁出现的有害种系变异。
Breast Cancer Res Treat. 2015 Sep;153(2):435-43. doi: 10.1007/s10549-015-3545-6. Epub 2015 Aug 22.